TRIRES2

Not Applicable

• Conditions: Healthy; Healthy Volunteers

• Registration Number: RPCEC00000403
• Lead Sponsor: Genomic Biotechnology Center – National Polytechnic Institute (IPN-Reynosa), Mexico

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2022-03-31
• Study Completion: 2022-08-29
• Results First Posted: 2022-08-29
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 28

Inclusion Criteria

1. Age between 25 and 55 years.
2. Body mass index (BMI) = 18.5 kg/m2 and less than 45 kg/m2.
3. Consume beef.
4. With a desire of lose weight and/or learn healthy eating habits.
5. Sign volunteer's written informed consent.

Exclusion Criteria

1. Type 1 or type 2 diabetes.
2. Hypertension (defined as systolic blood pressure =140 or diastolic blood pressure = 90 mmHg).
3. Chronic diseases (of the hepatic, renal and cardiovascular systems, pancreatitis or some type of malignancy condition) or acute at the time of inclusion.
4. Alcoholism and/or drug dependence.
5. Smoker (> 10 cigarettes a day).
6. Women who are pregnant or breastfeeding.
7. Medicine consumption of or dietary supplements.
8. The volunteer no longer wishes to be part of the study.
9. Inability to comply with the instructions of the investigation.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Anthropometric measurements and indexs. Measurement time: At baseline, at 2 and 4 weeks.<br>Weight (in Kg) Measurement time: At baseline, at 2 and 4 weeks.<br>Waist circumference (in cm). Measurement time: At baseline, at 2 and 4 weeks<br>Abdominal circumference (in cm). Measurement time: At baseline, at 2 and 4 weeks.<br>Hip circumference (in cm). Measurement time: At baseline, at 2 and 4 weeks<br>Waist-hip ratio (waist circumference/hip circumference in cm). Measurement time: At baseline, at 2 and 4 weeks<br>Body Mass Index-BMI (Weight/(Height*Height). (Weight measured in Kg and height in m). Measurement time: At baseline, at 2 and 4 weeks<br>

Secondary Outcome Measures

Name	Time	Method
Cholesterol, (value in mg/dL). Measurement time: at baseline (time 0), and at 4 weeks. <br>Triglycerides, (value in mg/dL). Measurement time: at baseline (time 0), and at 4 weeks. <br>HDL-c, (value in mg/dL). Measurement time: at baseline (time 0), and at 4 weeks. <br>LDL-c, (value in mg/dL). Measurement time: at baseline (time 0), and at 4 weeks. <br>VLDL-C, (value in mg/dL). Measurement time: at baseline (time 0), and at 4 weeks. <br>Atherogenic index, measurement time: at baseline (time 0), and at 4 weeks. <br>